AERI
Aerie Pharmaceuticals, Inc.
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
158 hedge funds and large institutions have $1.47B invested in Aerie Pharmaceuticals, Inc. in 2017 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 38 increasing their positions, 69 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
158
Holders Change
+8
Holders Change %
+5.33%
% of All Funds
3.94%
Holding in Top 10
3
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-50%
% of All Funds
0.07%
New
31
Increased
38
Reduced
69
Closed
14
Calls
$16.7M
Puts
$8.73M
Net Calls
+$7.98M
Net Calls Change
+$4.8M
Top Buyers
| 1 |
BlackRock
New York
|
+$118M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.7M |
| 3 |
SIG
Senator Investment Group
New York
|
+$18.1M |
| 4 |
Two Sigma Investments
New York
|
+$11.5M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$11.1M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$47.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$31.2M |
| 3 |
Jennison Associates
New York
|
-$13.3M |
| 4 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$9.56M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
-$8.39M |
